Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 993

1.

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF.

Cancer. 2005 Oct 1;104(7):1505-11.

2.

Malignancy in perinatally human immunodeficiency virus-infected children in the United States.

Kest H, Brogly S, McSherry G, Dashefsky B, Oleske J, Seage GR 3rd.

Pediatr Infect Dis J. 2005 Mar;24(3):237-42.

PMID:
15750460
3.

Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.

Calabresi A, Ferraresi A, Festa A, Scarcella C, Donato F, Vassallo F, Limina R, Castelli F, Quiros-Roldan E; Brescia HIV Cancer Study Group.

HIV Med. 2013 Sep;14(8):481-90. doi: 10.1111/hiv.12034. Epub 2013 Apr 7.

4.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort.

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.

PMID:
15770006
5.

Natural history of opportunistic disease in an HIV-infected urban clinical cohort.

Moore RD, Chaisson RE.

Ann Intern Med. 1996 Apr 1;124(7):633-42.

PMID:
8607591
7.

Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Møller H, Bower M.

J Clin Oncol. 2009 Feb 20;27(6):884-90. doi: 10.1200/JCO.2008.19.6626. Epub 2008 Dec 29.

PMID:
19114688
8.

Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.

Place RJ, Gregorcyk SG, Huber PJ, Simmang CL.

Dis Colon Rectum. 2001 Apr;44(4):506-12.

PMID:
11330577
9.

Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children.

Gaughan DM, Mofenson LM, Hughes MD, Seage GR 3rd, Ciupak GL, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Team.

Pediatrics. 2002 May;109(5):E74-4.

PMID:
11986480
10.

Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.

Sánchez JM, Ramos Amador JT, Fernández de Miguel S, González Tomée MI, Rojo Conejo P, Ferrnado Vivas P, Clemente Vivas J, Ruiz Contreras J, Nogales Espert A.

Pediatr Infect Dis J. 2003 Oct;22(10):863-7.

PMID:
14551485
11.

Prostate carcinoma among men with human immunodeficiency virus infection.

Crum NF, Spencer CR, Amling CL.

Cancer. 2004 Jul 15;101(2):294-9.

12.

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Ylitalo N, Brogly S, Hughes MD, Nachman S, Dankner W, Van Dyke R, Seage GR 3rd; Pediatric AIDS Clincial Trials Group Protocol 219C Team.

Arch Pediatr Adolesc Med. 2006 Aug;160(8):778-87.

PMID:
16894075
13.

Risk of cancers during interrupted antiretroviral therapy in the SMART study.

Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, Hidalgo J, Lourtau L, Neaton JD, Tambussi G, Abrams DI.

AIDS. 2007 Sep 12;21(14):1957-63.

PMID:
17721103
14.

HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.

Anekthananon T, Ratanasuwan W, Techasathit W, Rongrungruang Y, Suwanagool S.

J Med Assoc Thai. 2004 Feb;87(2):173-9.

PMID:
15061301
15.

Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, Liñares J, Gudiol F; Spanish Pneumococcal Infection Study Network (G03/103).

Arch Intern Med. 2005 Jul 11;165(13):1533-40.

PMID:
16009870
16.

Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.

Wood SM, Shah SS, Steenhoff AP, Rutstein RM.

Pediatrics. 2008 Jan;121(1):e150-6. Epub 2007 Dec 17.

PMID:
18086820
17.

Clinical progression in early and late stages of disease in a cohort of individuals infected with human immunodeficiency virus-2 in Guinea-Bissau.

Norrgren H, da Silva Z, Biague A, Andersson S, Biberfeld G.

Scand J Infect Dis. 2003;35(4):265-72.

PMID:
12839157
18.

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

International Collaboration on HIV and Cancer.

J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30.

PMID:
11078759
19.

Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans.

El-Serag HB, Giordano TP, Kramer J, Richardson P, Souchek J.

Clin Gastroenterol Hepatol. 2005 Feb;3(2):175-83.

PMID:
15704052
20.

Changing trends in clinical AIDS presentations and survival among HIV-1-infected women.

Charurat M, Blattner W, Hershow R, Buck A, Zorrilla CD, Watts DH, Paul M, Landesman S, Adeniyi-Jones S, Tuomala R; Women And Infants Transmission Study.

J Womens Health (Larchmt). 2004 Jul-Aug;13(6):719-30.

PMID:
15333287

Supplemental Content

Support Center